Lonza to expand bioscience testing offering with the acquisition of Redberry
Technology speeds up sterility testing from 14 to just 4 days
Advertisement
Lonza announced that it has signed an agreement to acquire Redberry SAS (Redberry), an innovative company specializing in rapid microbiology testing solutions using solid-phase cytometry (SPC) technology.
Redberry is a leader in SPC, providing rapid and highly precise microbial detection solutions for the pharmaceutical industry. Its state-of-the-art technology accelerates microbiology testing, delivering faster and more reliable results to ensure quality control and regulatory compliance. The innovative Red One™ System is designed for both rapid sterility and bioburden testing, to meet growing industry requirements for speed, sensitivity and ease of use.
In April 2025, Redberry announced the successful validation of its Red One™ rapid sterility testing method that delivers results in just four days. This breakthrough solution offers a robust, GMP-compliant alternative to traditional sterility testing, which typically requires a minimum incubation time of 14 days. This improved speed will help to meet the pharmaceutical industry's growing demand for faster product release without compromising safety or regulatory standards.
Lonza is a global leader in QC testing solutions, with a comprehensive offering including industry-leading endotoxin detection services to ensure the safety, efficacy, and compliance of biopharmaceutical products. The acquisition will strengthen Lonza’s testing capabilities with the addition of Redberry’s innovative Red One™ platform, delivering exceptional speed and sensitivity in microbial detection, as well as automation to pharmaceutical QC labs. The acquisition will further enhance Lonza’s capabilities for CDMO customers that require rapid and scalable QC solutions for short shelf-life products, reducing time-to-patient.
Mike Goetter, Head of Bioscience, Specialized Modalities, Lonza, said: “Our agreement to acquire Redberry marks a significant milestone in our commitment to advancing QC microbiology solutions in line with growing industry demand for rapid testing platforms. By integrating this cutting-edge technology into our portfolio, we are empowering customers with faster and simpler tools that lower compliance costs. It will also support scale-up, process, and product integrity for biologics and cell and gene therapy production. It is a strategic step forward in reducing risk, ensuring right first time delivery, and enhancing efficiency across the industry.”
Jonathan Macron, CEO, Redberry, said: "Joining Lonza is a natural next step in Redberry’s journey. Since its creation, Redberry has been dedicated to delivering faster, simpler, and reliable microbiological control. By combining Red One™ with Lonza’s global reach and expertise, we will scale our innovation to meet the growing needs of pharmaceutical and industrial manufacturers, accelerate product release and benefit patients worldwide, while together setting a new standard in pharmaceutical quality control."
The transaction is expected to close in Q4 2025, subject to closing conditions. The acquisition is not financially material, meaning it will not influence Lonza’s financial guidance.
Other news from the department business & finance
Most read news
More news from our other portals
Something is happening in the life science industry ...
This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.
See the theme worlds for related content
Topic World Cell Analysis
Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.
Topic World Cell Analysis
Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.
Last viewed contents
Plants under stress: How rye rearranges its genes
Revvity to Acquire ACD/Labs - Acquisition deepens Revvity Signals’ presence in research informatics while furthering its ongoing expansion into development and manufacturing solutions
Scientists identify 160 new drugs that could be repurposed against COVID-19 - Forty of these drugs have already entered clinical trials
Transparency for clinical trials - Transparency of study results in a public dashboard
Bertelsmann Investments acquires stake in AI-powered Israeli healthcare startup QuantHealth - AI-supported start-up company for clinical trial planning
First synthesis of open-chain N-stereogenic amines achieved - Study enables enantiomerically pure products for drug development.
The spider with the bee venom - New perspectives for the search for active substances against cell-based diseases - Researchers decode the toxin arsenal of the most poisonous native spider species
Is the immune system younger in the morning? - The internal clock of immune cells
Pancreatic cancer forms "synapses" - Pancreatic tumors use neurotransmitters to drive their own growth: Researchers hope to identify drugs that can block this process
A toxin with a useful twist - Their work opens the door to new applications in lab-on-a-chip technologies, biosensors, and artificial cell prototypes
Gene scissors in camouflage mode help in the search for cancer therapies - Overlooked genes for metastasis formation uncovered
